Interventional Cardiology Market

Interventional Cardiology is a kind of devices which is used in the treatment of cardiology area. Interventional Cardiology include cardiology catheters, guidewires, balloon catheters, coronary stents, fractional flow reserve (FFR), intravascular ultrasound.

Interventional Cardiology Market contains market size and forecasts of Interventional Cardiology in global, including the following market information:

Global Interventional Cardiology Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Interventional Cardiology Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Interventional Cardiology companies in 2021 (%)

The global Interventional Cardiology market was valued at 3248.4 million in 2021 and is projected to reach US$ 3908.9 million by 2028, at a CAGR of 2.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Cardiology Catheters Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Interventional Cardiology include Medtronic, Inc., Boston Scientific Corporation, Abbott Vascular, MINVASYS S.A.S., BIOTRONIK SE and Co. KG, Bard Peripheral Vascular?Inc, TERUMO CORPORATION, KANEKA and OrbusNeich Medical, BV, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Interventional Cardiology manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Interventional Cardiology Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Interventional Cardiology Market Segment Percentages, by Type, 2021 (%)

Cardiology Catheters

Guidewires

Balloon Catheters

Coronary Stents

Fractional Flow Reserve

Intravascular Ultrasound

Global Interventional Cardiology Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Interventional Cardiology Market Segment Percentages, by Application, 2021 (%)

Hospitals

Clinics

Others

Global Interventional Cardiology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Interventional Cardiology Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Interventional Cardiology revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Interventional Cardiology revenues share in global market, 2021 (%)

Key companies Interventional Cardiology sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Interventional Cardiology sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Medtronic, Inc.

Boston Scientific Corporation

Abbott Vascular

MINVASYS S.A.S.

BIOTRONIK SE and Co. KG

Bard Peripheral Vascular?Inc

TERUMO CORPORATION

KANEKA

OrbusNeich Medical, BV

Cordis Cashel

Kimal Plc

Volcano Corporation

Siemens Medical Solutions USA, Inc

Lepu

MicroPort